In vivo characterization of bioconjugate B cell toleragens with specificity for autoantibodies in antiphospholipid syndrome

This publication has 33 references indexed in Scilit:

• β2-glycoprotein I deficiency:
  Atherosclerosis, 2000
• Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry
  The American Journal of Medicine, 1996
• Recurrent stroke and thrombo‐occlusive events in the antiphospholipid syndrome
  Annals of Neurology, 1995
• Anticardiolipin antibodies are an independent risk factor for first ischemic stroke
  Neurology, 1993
• β2-Glycoprotein I Deficiency and the Risk of Thrombosis
  Thrombosis and Haemostasis, 1992
• Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease
  The Lancet, 1990
• Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
  Proceedings of the National Academy of Sciences, 1990
• Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
  The Lancet, 1990
• Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal.
  Annals of the Rheumatic Diseases, 1985
• Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.
  BMJ, 1983